Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $278,456 - $344,498
-31,751 Reduced 72.86%
11,826 $128,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $2,541 - $3,007
-265 Reduced 0.6%
43,577 $429,000
Q2 2023

Aug 11, 2023

SELL
$9.02 - $10.29 $95,846 - $109,341
-10,626 Reduced 19.51%
43,842 $437,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $417,873 - $556,861
-45,421 Reduced 45.47%
54,468 $523,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $104,465 - $138,488
-11,980 Reduced 10.71%
99,889 $1.11 Million
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $56,213 - $73,780
-6,629 Reduced 5.59%
111,869 $953,000
Q2 2022

Aug 12, 2022

BUY
$9.95 - $12.27 $24,228 - $29,877
2,435 Added 2.1%
118,498 $1.24 Million
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $14,508 - $22,776
1,479 Added 1.29%
116,063 $1.26 Million
Q4 2021

Feb 08, 2022

SELL
$12.09 - $14.68 $58,007 - $70,434
-4,798 Reduced 4.02%
114,584 $1.55 Million
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $468,308 - $534,754
35,344 Added 42.06%
119,382 $1.62 Million
Q2 2021

Aug 10, 2021

BUY
$12.97 - $16.15 $6,731 - $8,381
519 Added 0.62%
84,038 $1.2 Million
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $1.14 Million - $1.55 Million
83,519 New
83,519 $1.17 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Smith, Moore & Co. Portfolio

Follow Smith, Moore & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.